GlassScriptPhysician profile
Pablo Bedoya
NPI 1184800328
$13,438.59
in general payments reported to CMS, 2019-2025
51 companies · $3,467 in 2025
The $3,467 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.11 · 2020: $574 · 2021: $1,993 · 2022: $1,993 · 2023: $2,443 · 2024: $2,949 · 2025: $3,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,331 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $350 · Education: $148 · Travel and Lodging: $30.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,331.06 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $350.00 |
| Education | $148.04 |
| Travel and Lodging | $30.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,782.94 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $1,394.51 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $1,124.92 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $747.16 | 2019-2025 | Evenity, Tepezza, Prolia |
| Insulet Corporation | $716.63 | 2021-2025 | Omnipod |
| Radius Health, INC. | $659.21 | 2020-2025 | Tymlos |
| Amneal Pharmaceuticals LLC | $536.59 | 2020-2025 | Unithroid |
| Xeris Pharmaceuticals, INC. | $454.01 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $427.05 | 2021-2025 | |
| Antares Pharma, INC. | $337.87 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Novartis Pharmaceuticals Corporation | $317.56 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $297.79 | 2020-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.02 | 2021-2025 | Jardiance, Tradjenta |
| Mannkind Corporation | $262.08 | 2020-2025 | |
| Astellas Pharma US INC | $254.68 | 2024-2025 | Veozah |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $244.19 | 2022-2025 | Strensiq |
| Bayer Healthcare Pharmaceuticals INC. | $242.80 | 2021-2025 | |
| Cequr Corporation | $239.75 | 2023-2025 | Cequr Simplicity |
| Tolmar, INC. | $237.88 | 2023-2025 | Jatenzo |
| Lifescan, INC. | $233.60 | 2021-2023 | |
| Ibsa Pharma INC. | $224.77 | 2021-2025 | Tirosint, Licart, Flector |
| Esperion Therapeutics, INC. | $188.42 | 2021-2025 | Nexletol |
| Dexcom, INC. | $179.53 | 2021-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $168.42 | 2020-2023 | Steglatro, Janumet, Januvia |
| Recordati_rare_diseases_inc. | $153.77 | 2021-2025 | Isturisa, Signifor Lar |
| Abbvie INC. | $152.87 | 2020-2025 | Synthroid |
| Medtronic, INC. | $151.91 | 2021-2025 | Minimed 780g, Intellis Adaptivestim, Minimed 770g |
| Ascendis Pharma Endocrinology INC | $143.12 | 2023-2025 | Yorvipath |
| Enterra Medical, INC. | $121.13 | 2023 | |
| Beta Bionics, INC. | $113.34 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Clarus Therapeutics INC. | $103.84 | 2021 | |
| Corcept Therapeutics | $100.49 | 2023-2024 | Korlym |
| Amarin Pharma, INC. | $90.57 | 2020-2021 | |
| Sequel Med Tech, LLC | $88.35 | 2025 | Twiist |
| Neurocrine Biosciences, INC. | $81.71 | 2024-2025 | |
| Pfizer INC. | $67.94 | 2022-2023 | |
| Rhythm Pharmaceuticals, INC. | $62.92 | 2025 | Imcivree |
| Tandem Diabetes Care, INC. | $60.35 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Currax Pharmaceuticals LLC | $55.36 | 2022-2024 | Nexletol, Contrave |
| Horizon Therapeutics Plc | $50.70 | 2020-2021 | |
| Verity Pharmaceuticals INC. | $43.26 | 2024 | Tlando |
| Nevro Corp. | $41.86 | 2023 | Senza |
| Kyowa Kirin, INC. | $39.94 | 2023 | Crysvita |
| Inspire Medical Systems, INC. | $30.31 | 2024 | Inspire |
| Eusa Pharma (US) LLC | $29.20 | 2022 | |
| Halozyme INC | $27.94 | 2023 | |
| Averitas Pharma INC. | $18.34 | 2025 | Qutenza |
| Chiesi USA, INC. | $18.32 | 2025 | Myalept |
| Glaxosmithkline, LLC. | $16.71 | 2025 | Pediarix |
| Zealand Pharma US, INC. | $13.82 | 2022 | |
| Medtronic Minimed, INC. | $12.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pablo Bedoya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.